PACTR202307764415273

Targeted Fluid Resuscitation in Septic Shock: A Comparative Study between Capillary Refilling Time and Venous to Arterial PCO2

Ahmed Ismail·Not Applicable·Pan Africa Clinical Trials RegistryCompleted
Study focus
Sponsor & location
Primary sponsor
Ahmed Ismail
Funder
Ahmed I smail
Location
Egypt
Timeline & enrollment
Phase
Not Applicable
Start date
Sep 21, 2022
End date
Jun 23, 2023
Summary

Adequate cell perfusion as a result of resuscitation in septic shock patients has been considered a critical point in the prognosis of these patients. There have been many parameters that can be followed up to achieve this target as increase the difference between arterial PCO2 and venous PCO2 more than 6 mmHg that has been considered as a signal of tissue hypo perfusion in septic shock patients. Therefore, pursuing to normalize this difference less than 6 mmhg may lead to the risk of fluid overload. Peripheral perfusion, assessed by the capillary refill time (CRT), could be an effective alternative resuscitation target as recently demonstrated by the ANDROMEDA-SHOCK trial. We designed the present randomized controlled trial to address the impact of a CRT-targeted (CRT-T) fluid resuscitation versus the difference of arterial PCO2 to venous PCO2 on fluid balances within 24 h of septic shock diagnosis

ICD-10 classifications
Certain infectious and parasitic diseasesOther infestationsInfestation, unspecifiedOther specified infestationsOther infectious diseases
Data source
Registry
Pan Africa Clinical Trials Registry
Trial ID
PACTR202307764415273
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for PACTR202307764415273 through Pure Global AI's free database. This Not Applicable trial is sponsored by Ahmed Ismail and is currently Completed. The study focuses on Infections and Infestations.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.